Bellevue Life Sciences Acquisition (BLAC) Competitors $0.61 +0.05 (+9.58%) As of 09/9/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock BLAC vs. BTCY, IINN, NXL, MHUA, INBS, DHAI, FEMY, CODX, LYRA, and XAIRShould you be buying Bellevue Life Sciences Acquisition stock or one of its competitors? The main competitors of Bellevue Life Sciences Acquisition include Biotricity (BTCY), Inspira Technologies OXY B.H.N. (IINN), Nexalin Technology (NXL), Meihua International Medical Technologies (MHUA), Intelligent Bio Solutions (INBS), DIH Holding US (DHAI), Femasys (FEMY), Co-Diagnostics (CODX), Lyra Therapeutics (LYRA), and Beyond Air (XAIR). These companies are all part of the "medical equipment" industry. Bellevue Life Sciences Acquisition vs. Its Competitors Biotricity Inspira Technologies OXY B.H.N. Nexalin Technology Meihua International Medical Technologies Intelligent Bio Solutions DIH Holding US Femasys Co-Diagnostics Lyra Therapeutics Beyond Air Bellevue Life Sciences Acquisition (NASDAQ:BLAC) and Biotricity (NASDAQ:BTCY) are both small-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk, media sentiment and valuation. Do analysts rate BLAC or BTCY? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bellevue Life Sciences Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Biotricity 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals & insiders believe in BLAC or BTCY? 55.3% of Bellevue Life Sciences Acquisition shares are owned by institutional investors. Comparatively, 3.9% of Biotricity shares are owned by institutional investors. 33.7% of Bellevue Life Sciences Acquisition shares are owned by company insiders. Comparatively, 10.1% of Biotricity shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media favor BLAC or BTCY? In the previous week, Biotricity had 3 more articles in the media than Bellevue Life Sciences Acquisition. MarketBeat recorded 3 mentions for Biotricity and 0 mentions for Bellevue Life Sciences Acquisition. Biotricity's average media sentiment score of 0.16 beat Bellevue Life Sciences Acquisition's score of 0.00 indicating that Biotricity is being referred to more favorably in the news media. Company Overall Sentiment Bellevue Life Sciences Acquisition Neutral Biotricity Neutral Is BLAC or BTCY more profitable? Bellevue Life Sciences Acquisition has a net margin of 0.00% compared to Biotricity's net margin of -80.42%. Company Net Margins Return on Equity Return on Assets Bellevue Life Sciences AcquisitionN/A N/A N/A Biotricity -80.42%N/A -188.47% Which has more volatility and risk, BLAC or BTCY? Bellevue Life Sciences Acquisition has a beta of -0.08, suggesting that its stock price is 108% less volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.18, suggesting that its stock price is 18% more volatile than the S&P 500. Which has higher valuation and earnings, BLAC or BTCY? Bellevue Life Sciences Acquisition has higher earnings, but lower revenue than Biotricity. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/ABiotricity$12.06M1.52-$14.09M-$0.21-3.51 SummaryBiotricity beats Bellevue Life Sciences Acquisition on 5 of the 9 factors compared between the two stocks. Get Bellevue Life Sciences Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for BLAC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BLAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLAC vs. The Competition Export to ExcelMetricBellevue Life Sciences AcquisitionHolding Offices IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$2.46M$215.26M$2.55B$10.08BDividend YieldN/A3.17%2.51%4.52%P/E RatioN/A0.1726.4326.36Price / SalesN/A468.47111.61170.96Price / CashN/A123.7023.1559.76Price / BookN/A7.5431.936.22Net IncomeN/A-$11.59M$16.40M$270.65M7 Day Performance-16.10%-2.73%1.27%3.21%1 Month Performance0.61%-4.39%4.00%9.20%1 Year Performance-94.39%157.47%32.99%28.10% Bellevue Life Sciences Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLACBellevue Life Sciences AcquisitionN/A$0.61+9.6%N/A-94.9%$2.46MN/A0.00N/AHigh Trading VolumeBTCYBiotricityN/A$0.60+5.1%N/A+57.7%$14.91M$12.06M-0.5540News CoverageIINNInspira Technologies OXY B.H.N.2.7305 of 5 stars$1.16-1.7%$2.00+72.4%+13.6%$14.89MN/A0.0020Positive NewsShort Interest ↓Gap UpNXLNexalin Technology1.647 of 5 stars$0.81-4.3%$5.00+517.3%+0.3%$14.75M$170K-1.073Positive NewsGap UpMHUAMeihua International Medical TechnologiesN/A$0.42-2.7%N/A-61.2%$13.72M$96.90M0.00620Short Interest ↓INBSIntelligent Bio Solutions0.1739 of 5 stars$1.59+8.7%N/A-1.7%$13.14M$3.05M-0.7810DHAIDIH Holding US1.0632 of 5 stars$0.25-5.5%N/A-90.8%$12.72M$64.47M-0.85N/APositive NewsGap DownFEMYFemasys3.7156 of 5 stars$0.36-4.2%$7.33+1,935.3%-65.7%$12.25M$1.63M-0.4230Positive NewsHigh Trading VolumeCODXCo-Diagnostics4.0749 of 5 stars$0.33+4.4%$5.50+1,587.1%-75.5%$12.03M$3.91M-0.28100LYRALyra Therapeutics2.3201 of 5 stars$7.03-2.2%$100.00+1,322.5%-49.1%$11.82M$1.53M-0.2450Gap DownXAIRBeyond Air4.1159 of 5 stars$2.28+1.3%$11.00+382.5%-68.2%$11.76M$3.70M-0.1970Gap Down Related Companies and Tools Related Companies BTCY Competitors IINN Competitors NXL Competitors MHUA Competitors INBS Competitors DHAI Competitors FEMY Competitors CODX Competitors LYRA Competitors XAIR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLAC) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredWorld War 3? Everything Just Changed — and One Tiny Company Is at the Center of It.Trump immediately activated a $5.3 TRILLION AI missile shield — code-named Golden Dome — to stop drone swarms ...Angel Publishing | SponsoredLitecoin’s Creator Backs the World’s First TreasuryBitcoin's corporate adoption story has been written. Litecoin's is just beginning.The Tomorrow Investor | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Life Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellevue Life Sciences Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BLAC Stock Alerts